The oncolytic effects of unmodified CRAd5 did not result in obviously increased expression of annexin V (CRAd5 vs. uninfected), whereas inclusion of the TRAIL gene accelerated the apoptosis of glioma cells (A3 vs. CRAd5). Here, ANXA5 is linked to central nervous system cancer.